California Nanotechnologies Corp. (TSXV:CNO)
0.3200
-0.0150 (-4.48%)
Aug 7, 2026, 3:58 PM EST
TSXV:CNO Balance Sheet
Financials in millions USD. Fiscal year is March - February.
Millions USD. Fiscal year is Mar - Feb.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Cash & Equivalents | 0.28 | 0.21 | 0.53 | 0.84 | 0.22 | 0.05 |
Cash & Short-Term Investments | 0.28 | 0.21 | 0.53 | 0.84 | 0.22 | 0.05 |
Cash Growth | -40.57% | -61.19% | -36.55% | 289.44% | 320.87% | 157.01% |
Accounts Receivable | 0.76 | 0.57 | 1.23 | 0.43 | 0.18 | 0.35 |
Other Current Assets | 0.23 | 0.08 | 0.06 | 0.72 | 0.15 | 0 |
Total Current Assets | 1.26 | 0.86 | 1.83 | 1.99 | 0.54 | 0.41 |
Net Property, Plant & Equipment | 2.65 | 2.98 | 3.63 | 0.36 | 0.49 | 0.55 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Other Long-Term Assets | 0.04 | 0.04 | 0.04 | - | - | - |
Total Assets | 3.95 | 3.88 | 5.5 | 2.36 | 1.04 | 0.96 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Accounts Payable | 0.43 | 0.37 | 0.81 | 0.26 | 0.23 | 0.19 |
Accrued Expenses | 0.43 | 0.37 | 0.81 | 0.26 | 0.23 | 0.19 |
Short-Term Debt | - | - | - | - | - | 0.13 |
Current Portion of Leases | 0.34 | 0.33 | 0.32 | 0.02 | 0.02 | 0.02 |
Unearned Revenue | 0.13 | 0.11 | 0.02 | - | 0.18 | - |
Other Current Liabilities | 0.01 | 0.11 | 0.74 | 0.74 | 1.33 | 1.44 |
Total Current Liabilities | 0.91 | 0.92 | 1.88 | 1.03 | 1.76 | 1.78 |
Long-Term Leases | 0.7 | 0.98 | 1.31 | 0.21 | 0.23 | 0.25 |
Other Long-Term Liabilities | - | - | - | 0.98 | - | - |
Total Long-Term Liabilities | 0.7 | 0.98 | 1.31 | 1.18 | 0.23 | 0.25 |
Total Liabilities | 1.61 | 1.9 | 3.19 | 2.21 | 1.98 | 2.03 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Common Stock | 6.35 | 5.9 | 5.18 | 3.34 | 2.94 | 2.94 |
Additional Paid-in Capital | 2.34 | 1.98 | 1.18 | 0.69 | 0.38 | 0.33 |
Retained Earnings | -6.35 | -5.9 | -4.04 | -3.88 | -4.26 | -4.34 |
Shareholders' Equity | 2.34 | 1.98 | 2.32 | 0.15 | -0.95 | -1.07 |
Total Liabilities & Equity | 3.95 | 3.88 | 5.5 | 2.36 | 1.04 | 0.96 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Total Debt | 1.04 | 1.31 | 1.62 | 0.23 | 0.25 | 0.4 |
Net Cash (Debt) | -0.76 | -1.1 | -1.09 | 0.61 | -0.03 | -0.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.02 | -0.02 | -0.02 | 0.02 | -0.00 | -0.01 |
Book Value | 2.34 | 1.98 | 2.32 | 0.15 | -0.95 | -1.07 |
Book Value Per Share | 0.05 | 0.04 | 0.05 | 0.00 | -0.03 | -0.03 |
Tangible Book Value | 2.34 | 1.98 | 2.31 | 0.14 | -0.95 | -1.08 |
Tangible Book Value Per Share | 0.05 | 0.04 | 0.05 | 0.00 | -0.03 | -0.03 |